OMNISCAN 287 mg/mL

OMNISCAN 287 mg/mL is a gadodiamide injection used for contrast enhancement in MRI scans. This intravenous solution aids in visualizing internal structures for better diagnostic accuracy.

OMNISCAN 287 mg/mL is primarily used as a contrast agent in magnetic resonance imaging (MRI). It helps enhance the visibility of blood vessels, organs, and tissues, making it easier for healthcare professionals to detect abnormalities. This gadodiamide injection is commonly administered intravenously to improve the clarity of MRI images, aiding in the diagnosis of various conditions.

Common effects of OMNISCAN 287 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some individuals might experience a warm sensation or mild nausea. These effects are generally short-lived and resolve quickly.

OMNISCAN 287 mg/mL should be used with caution in individuals with a history of kidney problems or allergies to contrast agents. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the injection.

OMNISCAN 287 mg/mL may interact with certain medications or substances. It is advisable to discuss all current medications with a healthcare provider before using this contrast agent. Alcohol and other substances that affect kidney function should be avoided to minimize potential interactions.